These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19196721)

  • 21. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.
    May HT; Horne BD; Levy WC; Kfoury AG; Rasmusson KD; Linker DT; Mozaffarian D; Anderson JL; Renlund DG
    Am J Cardiol; 2007 Aug; 100(4):697-700. PubMed ID: 17697831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.
    Stoiser B; Mörtl D; Hülsmann M; Berger R; Struck J; Morgenthaler NG; Bergmann A; Pacher R
    Eur J Clin Invest; 2006 Nov; 36(11):771-8. PubMed ID: 17032344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
    Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea.
    Christ M; Thuerlimann A; Laule K; Klima T; Hochholzer W; Perruchoud AP; Mueller C
    Eur J Clin Invest; 2007 Nov; 37(11):834-41. PubMed ID: 17931382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
    Miller WL; Hartman KA; Burritt MF; Grill DE; Rodeheffer RJ; Burnett JC; Jaffe AS
    Circulation; 2007 Jul; 116(3):249-57. PubMed ID: 17592074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of B-type natriuretic peptide levels to body mass index after comprehensive lifestyle changes.
    Chainani-Wu N; Weidner G; Purnell DM; Frenda S; Merritt-Worden T; Kemp C; Kersh E; Ornish D
    Am J Cardiol; 2010 Jun; 105(11):1570-6. PubMed ID: 20494664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage-modulating cytokines predict adverse outcome in heart failure.
    Hohensinner PJ; Rychli K; Zorn G; Hülsmann M; Berger R; Mörtl D; Richter B; Huber K; Wojta J; Pacher R; Niessner A
    Thromb Haemost; 2010 Feb; 103(2):435-41. PubMed ID: 20076846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.
    Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O
    Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation.
    Nomura S; Ishii K; Inami N; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
    Transpl Immunol; 2007 Nov; 18(2):115-21. PubMed ID: 18005854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure.
    Cournot M; Mourre F; Castel F; Ferrières J; Destrac S
    Am Heart J; 2008 Jun; 155(6):986-91. PubMed ID: 18513508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease.
    Hébert MJ; Masse M; Vigneault N; Sirois I; Troyanov S; Madore F
    Am J Kidney Dis; 2001 Dec; 38(6):1271-6. PubMed ID: 11728960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis.
    Katsaros KM; Wiesbauer F; Speidl WS; Kastl SP; Huber K; Zorn G; Niessner A; Glogar D; Maurer G; Wojta J
    Thromb Haemost; 2011 May; 105(5):883-91. PubMed ID: 21359408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL.
    Jabłońska E; Kiersnowska-Rogowska B; Rogowski F; Parfieńczyk A; Puzewska W; Bukin M
    Rocz Akad Med Bialymst; 2005; 50():204-7. PubMed ID: 16358967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic threshold levels of NT-proBNP testing in primary care.
    Rosenberg J; Schou M; Gustafsson F; Badskjaer J; Hildebrandt P
    Eur Heart J; 2009 Jan; 30(1):66-73. PubMed ID: 19029123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
    Bassan R; Tura BR; Maisel AS
    Coron Artery Dis; 2009 Mar; 20(2):143-9. PubMed ID: 19293713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.
    Ryding AD; Kumar S; Worthington AM; Burgess D
    Anesthesiology; 2009 Aug; 111(2):311-9. PubMed ID: 19602961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).
    Masson S; Latini R; Anand IS; Barlera S; Judd D; Salio M; Perticone F; Perini G; Tognoni G; Cohn JN;
    J Card Fail; 2006 Jun; 12(5):375-80. PubMed ID: 16762801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health status identifies heart failure outpatients at risk for hospitalization or death.
    Heidenreich PA; Spertus JA; Jones PG; Weintraub WS; Rumsfeld JS; Rathore SS; Peterson ED; Masoudi FA; Krumholz HM; Havranek EP; Conard MW; Williams RE;
    J Am Coll Cardiol; 2006 Feb; 47(4):752-6. PubMed ID: 16487840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.